Aberrant splicing transcripts of ARHGEF3 play a critical role in ccRCC progression and development and can be processed directly and presented to CD8+ T cells to elicit an immune response. This evidence concerns the gene ARHGEF3 and nonpapillary renal cell carcinoma.